Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huashan Hospital COVID-19 Prevention and Treatment Formula No. 2 is a Traditional Chinese Medicine (TCM) formula developed by Huashan Hospital, affiliated with Fudan University in Shanghai, China, for the prevention and treatment of COVID-19. As a TCM formula, it is typically a combination of various herbs intended to address symptoms and support the body's response to the infection. Specific details regarding its exact composition and precise mechanisms of action are not publicly available. Generally, TCM approaches to viral respiratory infections like COVID-19 aim to clear heat, resolve dampness, detoxify, regulate immune function, and alleviate symptoms such as fever, cough, and fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huashan Hospital COVID-19 Prevention and Treatment Formula No. 2.